Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This billing and coding article (A58893) provides billing/coding guidance and points to Local Coverage Determination L39139 for coverage of amniotic and placental-derived product injections/applications for musculoskeletal, non-wound indications. Specific covered indications, exclusions, documentation requirements, and frequency limits are defined in LCD L39139 and must be consulted for claims adjudication.

"Coverage for amniotic and placental-derived product injections/applications for musculoskeletal, non-wound indications is determined by Local Coverage Determination L39139; consult LCD L39139 for s..."

Sign up to see full coverage criteria, indications, and limitations.